|
WO2020047158A1
|
|
Therapeutic medications for the sphenopalatine ganglion
|
|
WO2020047159A1
|
|
Skin therapeutics
|
|
EP2512507A1
|
|
Treatment of nasal and sinus disorders
|
|
WO2011057301A1
|
|
Treatment of sleep disordered breathing with neurotoxin
|
|
US2012114697A1
|
|
Treatment of holocrine gland dysfunction with clostridia neurotoxins
|
|
US2009142430A1
|
|
Methods for Preventing or Treating Complications of Airway Control Devices
|
|
US2008188947A1
|
|
Methods and devices for treating sleep apnea and snoring
|
|
US2008081049A1
|
|
Treatment of fine wrinkles with clostridia neurotoxins
|
|
US2008112981A1
|
|
Treatment of fine wrinkles with clostridia neurotoxins
|
|
AU2007203272A1
|
|
Methods for Using Tetanus Toxin for Beneficial Purposes in Animals (Mammals)
|
|
US2007261701A1
|
|
Methods and devices for treating sleep apnea and snoring
|
|
EP1599213A2
|
|
Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
|
|
US2006008462A1
|
|
Treatment of mammalian reaction of IgE interactions
|
|
CA2496005A1
|
|
Use of botulinum toxin for the treatment of fine wrinkles and pore size
|
|
CA2413301A1
|
|
Methods for using tetanus toxin for benificial purposes in animals (mammals)
|
